Pancreatic Cancer

 

Combination Chemotherapy + Radiation + Surgery for Localized Pancreatic Cancer (FHCRC-6511)
A Phase II Study Induction Chemotherapy, Neoadjuvant Chemoradiotherapy, Surgical Resection and Adjuvant Chemotherapy for Patients with Locally Advanced, Resectable Pancreatic Adenocarcinoma

Investigator: Andrew Coveler, MD;   Conditions: Pancreatic Cancer;    Status: Recruiting;   Study ID: NCT00609336